Literature DB >> 22310242

Defining the expressed breast cancer kinome.

Alicia A Midland1, Martin C Whittle, James S Duncan, Amy N Abell, Kazuhiro Nakamura, Jon S Zawistowski, Lisa A Carey, H Shelton Earp, Lee M Graves, Shawn M Gomez, Gary L Johnson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22310242      PMCID： PMC3317564          DOI： 10.1038/cr.2012.25

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   25.617


× No keyword cloud information.
  18 in total

1.  High frequency of mutations of the PIK3CA gene in human cancers.

Authors:  Yardena Samuels; Zhenghe Wang; Alberto Bardelli; Natalie Silliman; Janine Ptak; Steve Szabo; Hai Yan; Adi Gazdar; Steven M Powell; Gregory J Riggins; James K V Willson; Sanford Markowitz; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Journal:  Science       Date:  2004-03-11       Impact factor: 47.728

2.  Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors.

Authors:  Marcus Bantscheff; Dirk Eberhard; Yann Abraham; Sonja Bastuck; Markus Boesche; Scott Hobson; Toby Mathieson; Jessica Perrin; Manfred Raida; Christina Rau; Valérie Reader; Gavain Sweetman; Andreas Bauer; Tewis Bouwmeester; Carsten Hopf; Ulrich Kruse; Gitte Neubauer; Nigel Ramsden; Jens Rick; Bernhard Kuster; Gerard Drewes
Journal:  Nat Biotechnol       Date:  2007-08-26       Impact factor: 54.908

3.  Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.

Authors:  Henrik Daub; Jesper V Olsen; Michaela Bairlein; Florian Gnad; Felix S Oppermann; Roman Körner; Zoltán Greff; György Kéri; Olaf Stemmann; Matthias Mann
Journal:  Mol Cell       Date:  2008-08-08       Impact factor: 17.970

Review 4.  Mechanisms of disease: Oncogene addiction--a rationale for molecular targeting in cancer therapy.

Authors:  I Bernard Weinstein; Andrew K Joe
Journal:  Nat Clin Pract Oncol       Date:  2006-08

5.  Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinib.

Authors:  Floriana Morgillo; Jong Kyu Woo; Edward S Kim; Waun Ki Hong; Ho-Young Lee
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

Review 6.  Targeting phosphatidylinositol 3 kinase (PI3K)-Akt beyond rapalogs.

Authors:  Shin Ogita; Patricia Lorusso
Journal:  Target Oncol       Date:  2011-05-06       Impact factor: 4.493

Review 7.  Clinical trials in triple negative breast cancer.

Authors:  Katherine E Reeder-Hayes; Lisa A Carey; William M Sikov
Journal:  Breast Dis       Date:  2010

8.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.

Authors:  Ben Langmead; Cole Trapnell; Mihai Pop; Steven L Salzberg
Journal:  Genome Biol       Date:  2009-03-04       Impact factor: 13.583

Review 9.  Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health.

Authors:  William H Chappell; Linda S Steelman; Jacquelyn M Long; Ruth C Kempf; Stephen L Abrams; Richard A Franklin; Jörg Bäsecke; Franca Stivala; Marco Donia; Paolo Fagone; Graziella Malaponte; Maria C Mazzarino; Ferdinando Nicoletti; Massimo Libra; Danijela Maksimovic-Ivanic; Sanja Mijatovic; Giuseppe Montalto; Melchiorre Cervello; Piotr Laidler; Michele Milella; Agostino Tafuri; Antonio Bonati; Camilla Evangelisti; Lucio Cocco; Alberto M Martelli; James A McCubrey
Journal:  Oncotarget       Date:  2011-03

10.  EGFR associated expression profiles vary with breast tumor subtype.

Authors:  Katherine A Hoadley; Victor J Weigman; Cheng Fan; Lynda R Sawyer; Xiaping He; Melissa A Troester; Carolyn I Sartor; Thais Rieger-House; Philip S Bernard; Lisa A Carey; Charles M Perou
Journal:  BMC Genomics       Date:  2007-07-31       Impact factor: 3.969
View more
  12 in total

Review 1.  Affinity-based profiling of endogenous phosphoprotein phosphatases by mass spectrometry.

Authors:  Brooke L Brauer; Kwame Wiredu; Sierra Mitchell; Greg B Moorhead; Scott A Gerber; Arminja N Kettenbach
Journal:  Nat Protoc       Date:  2021-09-13       Impact factor: 13.491

2.  A Quantitative Chemical Proteomic Strategy for Profiling Phosphoprotein Phosphatases from Yeast to Humans.

Authors:  Scott P Lyons; Nicole P Jenkins; Isha Nasa; Meng S Choy; Mark E Adamo; Rebecca Page; Wolfgang Peti; Greg B Moorhead; Arminja N Kettenbach
Journal:  Mol Cell Proteomics       Date:  2018-09-18       Impact factor: 5.911

3.  Characterization of DNA variants in the human kinome in breast cancer.

Authors:  Divyansh Agarwal; Yuan Qi; Tingting Jiang; Xiuping Liu; Weiwei Shi; Vikram B Wali; Benjamin Turk; Jeffrey S Ross; W Fraser Symmans; Lajos Pusztai; Christos Hatzis
Journal:  Sci Rep       Date:  2015-09-30       Impact factor: 4.379

Review 4.  Protein Kinase Targets in Breast Cancer.

Authors:  Marilina García-Aranda; Maximino Redondo
Journal:  Int J Mol Sci       Date:  2017-11-27       Impact factor: 5.923

5.  Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypes.

Authors:  Margarite D Matossian; Steven Elliott; Van T Hoang; Hope E Burks; Theresa B Phamduy; Douglas B Chrisey; William J Zuercher; David H Drewry; Carrow Wells; Bridgette Collins-Burow; Matthew E Burow
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

Review 6.  Recent advances in methods to assess the activity of the kinome.

Authors:  Maria Radu; Jonathan Chernoff
Journal:  F1000Res       Date:  2017-06-26

7.  Genome-wide effects of MELK-inhibitor in triple-negative breast cancer cells indicate context-dependent response with p53 as a key determinant.

Authors:  Marisa Simon; Fahmi Mesmar; Luisa Helguero; Cecilia Williams
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

Review 8.  Proteomic discovery of host kinase signaling in bacterial infections.

Authors:  Erik Richter; Jörg Mostertz; Falko Hochgräfe
Journal:  Proteomics Clin Appl       Date:  2016-09-09       Impact factor: 3.494

9.  Proteomic analysis defines kinase taxonomies specific for subtypes of breast cancer.

Authors:  Kyla A L Collins; Timothy J Stuhlmiller; Jon S Zawistowski; Michael P East; Trang T Pham; Claire R Hall; Daniel R Goulet; Samantha M Bevill; Steven P Angus; Sara H Velarde; Noah Sciaky; Tudor I Oprea; Lee M Graves; Gary L Johnson; Shawn M Gomez
Journal:  Oncotarget       Date:  2018-01-29

Review 10.  The dynamic nature of the kinome.

Authors:  Lee M Graves; James S Duncan; Martin C Whittle; Gary L Johnson
Journal:  Biochem J       Date:  2013-02-15       Impact factor: 3.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.